SAN FRANCISCO, Nov. 6, 2025 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the third ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback